According to the research report released by JPMorgan, considering the optimistic outlook for Goldwind Science& Technology's (02208) first-half performance and management's positive prospects, it believes that the stock price does not reflect the profit recovery and reiterates its "shareholding" rating. The H-share target price has been raised from HKD 4.9 to HKD 5.6, and the company's profit forecast for the fiscal years 2024 to 2026 has been adjusted upward by 12% to 16%. Goldwind Science& Technology's management predicts that its profitability will improve in the second half of this year and beyond, and overseas orders will also increase between 2023 and 2025.